Skip to content
CancerIndex

Publication

Validation of the newly introduced Deauville score 5a for patients treated for advanced-stage classic Hodgkin lymphoma.

Simon Leiders, Dominic Ufton, Helen Kaul, Jasmin Weindler, Johannes Rosenbrock, Michael Fuchs, Markus Dietlein, Urban Novak, Martin Fehr, Richard Greil, Mark Hertzberg, Josée M Zijlstra, Alexander Fosså, Peter Kamper, Daniel Molin, Peter Borchmann, Carsten Kobe, Justin Ferdinandus

Blood advancesSep 22, 2026PMID 42379221doi:10.1182/bloodadvances.2026019712 PMC13578970Journal ArticleRandomized Controlled TrialpubmedProvenance
Source
PubMed
Retrieved
Sep 29, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260929-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

The Lugano Imaging Committee recently refined the Deauville score (DS), subdividing DS5 into DS5a (>2× liver uptake without new lesions) and DS5b (new lesions). We investigated whether this improves prognostic discrimination at interim positron emission tomography (PET) after 2 cycles (PET-2) in…

Read on PubMed

Linked entities

Linked entities (3)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 2

Candidate 1

Registered trialsNCT00515554NCT02661503

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.